Nabriva Therapeutics plc

Ownership Transactions Reported by 15 Insiders

Location
25 28 North Wall Quay, Dublin, Ireland

There are no Buy or Sell transactions made by insiders since 8/21/2023

Nabriva Therapeutics plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Robert Crotty Gen Counsel & Corp Secretary $61.8K Aug 31, 2021
Colin MD Broom Director $54.8K Aug 2, 2022
Charles A. Rowland Jr Director $22.9K Aug 2, 2021
Steven P. Gelone Director $21.4K Jan 29, 2023
Theodore R. Schroeder Director $18K Jan 29, 2023
Stephen W. Webster Director $17.2K Aug 2, 2022
Daniel D. Burgess Director $15.6K Aug 2, 2022
Carrie L. Bourdow Director $14.9K Aug 1, 2022
Lisa Dalton Director $13.7K Jul 31, 2022
Mark Corrigan Director $10.8K Aug 2, 2022
H. Michael Hogan III Chief Executive Officer Jul 6, 2023
Christine J. Guico-Pabia Chief Medical Officer Aug 11, 2022
Daniel Dolan Chief Financial Officer Aug 11, 2022
David Maggio Chief Financial Officer Jun 30, 2023
J. Christopher Naftzger General Counsel and Corp Sec Aug 11, 2022

Recent Insider Transactions by Companies or Individuals for Nabriva Therapeutics plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.